Diurnal variation and size dependence of the hygroscopicity of organic aerosol at a forest site in Wakayama, Japan: their relationship to CCN concentrations

Formation of biogenic secondary organic aerosol (BSOA) and its subsequent evolution can modify the hygroscopicity of the organic aerosol component (OA) in the forest atmosphere, and affect the concentrations of cloud condensation nuclei (CCN) there. In this study, size-resolved aerosol hygroscopic growth at 85&thinsp;% relative humidity and size-resolved aerosol composition were measured using a hygroscopic tandem differential mobility analyzer and an aerosol mass spectrometer, respectively, at a forest site in Wakayama, Japan, in August and September 2015. The hygroscopicity parameter of OA (κorg) presented daily minima in the afternoon hours, and it also showed an increase with the increase in particle dry diameter. The magnitudes of the diurnal variations in κorg for particles with dry diameters of 100 and 300&thinsp;nm were on average 0.091 and 0.096, respectively, and the difference in κorg between particles with dry diameters of 100 and 300&thinsp;nm was on average 0.056. The relative contributions of the estimated fresh BSOA and regional OA to total OA could explain 40&thinsp;% of the observed diurnal variations and size dependence of κorg. The hygroscopicity parameter of fresh BSOA was estimated to range from 0.089 to 0.12 for particles with dry diameters from 100 to 300&thinsp;nm. Compared with the use of time- and size-resolved κorg, the use of time- and size-averaged κorg leads to under- and over-estimation of the fractional contribution of OA to CCN number concentrations in the range from −5.0&thinsp;% to 26&thinsp;%. This indicates that the diurnal variations and size dependence of κorg strongly affect the overall contribution of OA to CCN concentrations. The fractional contribution of fresh BSOA to CCN number concentrations could reach 0.28 during the period of intensive BSOA formation. The aging of the fresh BSOA, if it occurs, increases the estimated contribution of BSOA to CCN number concentrations by 52&thinsp;%–84&thinsp;%.</p

Universal Resistances of the Quantum RC circuit

We examine the concept of universal quantized resistance in the AC regime through the fully coherent quantum RC circuit comprising a cavity (dot) capacitively coupled to a gate and connected via a single spin-polarized channel to a reservoir lead. As a result of quantum effects such as the Coulomb interaction in the cavity and global phase coherence, we show that the charge relaxation resistance $R_q$ is identical for weak and large transmissions and it changes from $h/2e^2$ to $h/e^2$ when the frequency (times $\hbar$) exceeds the level spacing of the cavity; $h$ is the Planck constant and $e$ the electron charge. For large cavities, we formulate a correspondence between the charge relaxation resistance $h/e^2$ and the Korringa-Shiba relation of the Kondo model. Furthermore, we introduce a general class of models, for which the charge relaxation resistance is universal. Our results emphasize that the charge relaxation resistance is a key observable to understand the dynamics of strongly correlated systems.Comment: 12 pages, 3 figure

Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-Analysis

OBJECTIVE: To evaluate the effectiveness and safety of heat-killed M. vaccae added to chemotherapy of never-treated tuberculosis (TB) patients. METHODS: The databases of Medline, Embase, Biosis, Cochrane Central Register of Controlled Trials, SCI, CBM, VIP and CNKI were searched. Randomized controlled trials (RCT) and Controlled clinical trials (CCT) comparing M. vaccae with or without a placebo-control injection as adjuvant therapy in the chemotherapy of never-treated TB patients were included. Two reviewers independently performed data extraction and quality assessment. Data were analyzed using RevMan 5.0 software by The Cochrane Collaboration. RESULTS: Fifty four studies were included. At the end of the follow-up period, Pooled RR (Risk Ratio) and its 95% CI of sputum smear conversion rate were 1.07 (1.04, 1.10) in TB patients without complications, 1.17 (0.92, 1.49) in TB patients with diabetes mellitus, 1.02 (0.94, 1.10) in TB patients with hepatitis B, and 1.46 (0.21, 10.06) in TB patients with pneumosilicosis. In elderly TB patients the RR was 1.22 (1.13, 1.32). Analysis of each time point during the follow-up period showed that M. vaccae could help to improve the removal of acid-fast bacilli from the sputum, and promote improvement of radiological focal lesions and cavity closure. Compared with the control group, the differences in levels of immunological indicators of Th1 such as IL-2 and TNF-α were not statistical significant (P = 0.65 and 0.31 respectively), and neither was that of IL-6 produced by Th2 (P = 0.52). An effect of M. vaccae of prevention of liver damage was found in TB patients with hepatitis B (RR 0.20 and 95% CI (0.12, 0.33). No systemic adverse events were reported. CONCLUSION: Added to chemotherapy, M. vaccae is helpful in the treatment of never-treated TB patients in terms of improving both sputum conversion and X-ray appearances

Muon (g-2) Technical Design Report

The Muon (g-2) Experiment, E989 at Fermilab, will measure the muon anomalous magnetic moment a factor-of-four more precisely than was done in E821 at the Brookhaven National Laboratory AGS. The E821 result appears to be greater than the Standard-Model prediction by more than three standard deviations. When combined with expected improvement in the Standard-Model hadronic contributions, E989 should be able to determine definitively whether or not the E821 result is evidence for physics beyond the Standard Model. After a review of the physics motivation and the basic technique, which will use the muon storage ring built at BNL and now relocated to Fermilab, the design of the new experiment is presented. This document was created in partial fulfillment of the requirements necessary to obtain DOE CD-2/3 approval